Lynette Rike

Lynette Rike is an experienced professional in the biopharmaceutical and oncology sales sectors, currently serving as an Oncology Territory Manager at Stemline Therapeutics since April 2023, focusing on the launch of elecestrant for advanced ER+/HER2-breast cancer patients. Previously, Lynette worked at Amgen for nearly eleven years as an Executive Biopharmaceutical Representative, selling Enbrel and Sensipar across various specialties. Lynette's extensive background includes a successful tenure at Novartis, achieving multiple sales awards and training positions, and earlier roles in account management and clinical dietetics. Lynette holds two Bachelor of Science degrees in Dietetics from the University of North Dakota.